High left ventricular mass (LVM) is a heritable risk factor for heart failure and sudden death, but its genetic regulators are not well defined. McDermott-Roe et al. used several rat models to identify that reduced expression of endonuclease G (Endog) is associated with a blood-pressure-independent increase in cardiac mass. In vitro, reduced Endog expression caused cardiomyocyte hypertrophy as well as increased levels of mitochondrial reactive oxygen species, a signal known to promote hypertrophy. In line with these findings, Endog−/− mice were found to exhibit mitochondrial dysfunction and depletion, cardiac hypertrophy, and cardiac steatosis. Analysis of human cardiac expression data located ENDOG within a mitochondrial gene network, and further experiments showed that ENDOG is regulated by PCG1α and ERRα, two key transcription factors for mitochondrial and heart function. Finally, the authors show that ENDOG binds directly to mitochondrial DNA and seems to regulate mitochondrial biogenesis. These data define ENDOG as a regulator of mitochondrial function and might help to define the molecular mechanisms underlying blood-pressure-independent cardiac hypertrophy in humans.
- Written by editorial staff. © 2011. Published by The Company of Biologists Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium provided that the original work is properly cited and all further distributions of the work or adaptation are subject to the same Creative Commons License terms.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
Review – Mouse models of metastasis: progress and prospects
Currently available mouse models of metastasis are reviewed by Valerie G. Brunton and colleagues, with a focus on the mechanistic and therapeutic insights that have been gained by their application, strengths and weaknesses of different models and key technological advances that are generating more refined models.
Perspective – Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
Victorio M. Pozo Devoto and Tomas L. Falzone review the α-synuclein structural, biophysical and biochemical properties that influence relevant mitochondrial physiological processes such as fusion-fission, transport and clearance, and propose that α-synuclein contributes to the mitochondrial defects that are associated with Parkinson's disease.
Editors’ choice – Loss of Cln5 causes altered neurogenesis in a mouse model of a childhood neurodegenerative disorder
In our latest Editors' choice article, Katja M. Kanninen and colleagues examine neurogenesis in the neuronal ceroid lipofuscinoses – neurodegenerative disorders caused by loss of the Cln5 gene – and report a novel function of the CLN5 protein.
Call for papers: Cancer metabolism special collection
DEADLINE EXTENDED TO MONDAY 16TH OCTOBER 2016
DMM invites you to submit original research for a special collection focused on the dysregulation of metabolic pathways in cancer initiation, progression and resistance to treatment. This ongoing collection will be launched with a special issue scheduled for publication in spring 2018, with the special issue guest edited by Almut Schulze (University of Würzberg, Germany) and Mariia Yuneva (Crick Institute, London, UK).
Find out more here.
First person – Lucía Zacchi
We continue our new series of interviews with the first authors of articles published in DMM, giving authors the opportunity to promote themselves alongside their papers. In this issue we feature Lucía Zacchi, first author on a Resource article describing a novel yeast screen to identify genetic modifiers of protein levels in dystonia.